All notes
93 entries across chemistry, analytical methods, storage, and regulatory topics.
-
Dry ice and peptide samples: sublimation, carbon dioxide, and the pH shift nobody records
Dry ice is not an inert cold source. It fills a shipper with carbon dioxide, and a sample thawed from that atmosphere can reach a pH it was never formulated at.
-
The DMF reference on a peptide listing: what a Drug Master File is, and what invoking one would require
A Drug Master File is a confidential FDA submission that means something only inside a referencing drug application — not a quality grade a listing can claim.
-
Proline cis–trans isomerization: when two chromatographic peaks are one peptide
A proline-containing peptide can elute as two peaks of identical mass with no impurity present. What causes conformational doubling, and how to identify it.
-
System suitability testing: what the injections before your sample are meant to prove
A purity figure is only as good as the instrument that made it. What resolution, tailing, and injection-repeatability checks establish — and what they cannot.
-
Native chemical ligation: how long peptides get built when stepwise synthesis runs out of room
Stepwise chain assembly degrades with length. Chemoselective ligation joins purified fragments instead — and leaves a different impurity record behind.
-
Sterile filtration of peptide solutions: membrane chemistry, adsorptive loss, and what passes through
A 0.22 µm filter is rated by pore size, but for peptides the membrane polymer matters more: what binds, what leaches, and how much never reaches the vial.
-
"GMP-grade" on a peptide listing: what ICH Q7 covers and where GMP actually begins
GMP is a claim about a manufacturer’s quality system, not a property of a molecule. Where that boundary falls in peptide synthesis, and why a CoA cannot show it.
-
Universal detection for peptides without a chromophore: charged aerosol detection and ELSD against UV
Many synthetic peptides absorb poorly above 250 nm. How CAD and ELSD respond by mass rather than absorbance, and what that changes on a purity chromatogram.
-
Quantitative NMR for synthetic peptides: an absolute assay that does not require a matching reference standard
qNMR ties peptide content to a certified internal standard through proton count alone. What the technique measures, where it outperforms AAA, and its limits.
-
Edman degradation: the sequence question that intact mass cannot close
Intact mass confirms composition, not order. What stepwise N-terminal sequencing still establishes about a synthetic peptide, and where the chemistry runs out.
-
The 40-residue line: where a peptide stops being a drug and becomes a biologic
One number decides whether an amino acid polymer is regulated as a drug or a biological product. Where the 40-residue threshold came from and how it is counted.
-
Glass transition and collapse temperature: the thermal numbers behind lyophilized peptide stability
A lyophilized peptide cake is an amorphous glass. Two temperatures govern it: the collapse temperature during drying and the glass transition in storage.
-
Stability programs and retest dates: where a lyophilized peptide's storage window actually comes from
A peptide vial's storage window is the output of a stability study, not an estimate. ICH Q1A defines how those studies are designed and what the date means.
-
Reference standards in peptide analysis: what the purity number is measured against
Every purity and content figure on a peptide COA is a comparison. The material on the other side of that comparison is the reference standard, and its qualification sets the ceiling on what the result can mean.
-
Impurity thresholds for synthetic peptides: the number underneath the purity figure
A purity result is a boundary. Threshold frameworks define how far below it anyone is obliged to look — and that definition changed for peptides in July 2026.
-
Fmoc versus Boc solid-phase synthesis: how the protecting-group strategy shapes the final material
Two protection schemes build the same sequence by different chemistry. The choice propagates into the impurity fingerprint and the residual solvent profile.
-
Ion-exchange chromatography for peptide charge variants: what RP-HPLC misses
Reversed-phase HPLC separates by hydrophobicity, so charge variants often co-elute with the main peak. Ion-exchange chromatography resolves them by net charge.
-
Container closure integrity: how vial seals are tested and what a leak actually costs
A vial's seal is a measurable variable, not an assumption: how leakage limits are defined, why dye ingress fell out of favor, and what headspace gas reveals.
-
Macrocyclization and conformational constraint in peptide research
Closing a peptide into a ring reshapes its conformational ensemble and protease susceptibility — and quietly disables several standard characterization methods.
-
Sub-visible particulate matter in reconstituted peptide solutions
A solution that looks clear can still carry tens of thousands of particles per container. What light obscuration counts, what it misses, and why peptides complicate it.
-
Capillary electrophoresis as an orthogonal purity method for synthetic peptides
RP-HPLC separates peptides by hydrophobicity; capillary electrophoresis by charge-to-size ratio. Where the two disagree is where the information sits.
-
Elastomeric closures: extractables, leachables, and stopper chemistry in peptide vial storage
The rubber stopper is the most chemically complex part of a peptide vial. Elastomer formulation, coatings, and what actually migrates into the solution.
-
Circular dichroism and peptide higher-order structure: what a CD spectrum can and cannot settle
CD reports backbone conformation, not sequence. What the far-UV spectrum of a synthetic peptide actually establishes, and the ways it is routinely over-read.
-
The July 2026 PCAC meeting: seven peptides and how the 503A bulks list actually works
BPC-157, KPV, TB-500, MOTS-c, Emideltide, Semax and Epitalon went before FDA's compounding advisory committee. What that process does and does not decide.
-
Fatty acid acylation and albumin binding: the structural chemistry behind long-acting peptides
A gamma-Glu spacer, two ethylene glycol units and a C18 diacid turn a peptide with a two-minute half-life into one measured in days. Here is the chemistry.
-
What "validated method" means on a peptide certificate: ICH Q2, verification, and the limits of system suitability
A certificate calling its purity method validated is making a narrowly scoped claim. What ICH Q2 requires, and why a passing system suitability run is not it.
-
Residual solvents in synthetic peptides: what ICH Q3C covers, what it does not, and why headspace GC struggles with the ones that matter
Every peptide passes through DMF, piperidine, TFA and acetonitrile. The solvents most likely to remain are the ones the standard method is worst at seeing.
-
Lyoprotectants and bulking agents: what else is in a lyophilized peptide vial
Mannitol builds the cake and sucrose protects the peptide. These are different chemical jobs, and the excipient that does one usually cannot do the other.
-
Nitrosamine impurities in peptides: where NDSRIs come from and why routine testing does not look for them
Nitrosation needs a secondary amine and a nitrosating agent. Peptides supply both more often than expected, and the product is invisible to area-percent purity.
-
Glass vial chemistry: borosilicate types, delamination, and what the container contributes to peptide stability
Type I borosilicate glass is not inert. A look at glass composition, silanol surface chemistry, delamination risk, and container effects on stored peptides.
-
UV quantitation of peptides: what A280 measures, and what it quietly assumes
UV absorbance is the fastest way to estimate peptide concentration. Its accuracy hinges on extinction coefficients, chromophore content, and matrix effects.
-
Amino acid analysis: the reference method that anchors peptide content to an absolute scale
HPLC purity is a relative measurement. Amino acid analysis is the absolute one. How hydrolysis, derivatization, and internal standards produce peptide content.
-
Pyroglutamate formation: the N-terminal cyclization that hides in a −17 Da mass shift
N-terminal glutamine can cyclize to pyroglutamate, shifting mass by −17 Da and blocking the free amine. The mechanism, kinetics, and analytical signatures.
-
Peptide mapping and enzymatic digestion: localizing the modifications intact mass can't place
Intact mass shows that a modification happened, not where. How peptide mapping and LC-MS/MS localize oxidation, deamidation, and sequence errors to the residue.
-
Temperature excursions and mean kinetic temperature: what transit conditions mean for peptide stability
A shipment that sat in a hot truck raises a kinetics question, not a binary one. Arrhenius behavior and mean kinetic temperature frame the excursion problem.
-
Oxidative degradation in stored peptides: which residues go first, and what drives them
Oxidation is the most common storage-related degradation pathway in peptides, but it is not uniform. A look at susceptible residues and what drives them.
-
Disulfide scrambling: why two peptides with identical mass can be different molecules
Disulfide isomers share a sequence, a formula, and a mass. What separates them is connectivity — and most routine peptide identity testing cannot see it.
-
Residual moisture in lyophilized peptides: what a Karl Fischer number actually measures
Water content is the least-read number on a peptide CoA. What Karl Fischer titration measures, how it differs from loss on drying, and why the value moves.
-
Forced degradation studies: how a peptide purity method proves it can actually see degradation
A purity assay is only meaningful if it detects the degradants that form. How stress testing under acid, base, oxidation, heat, and light validates peptide methods.
-
Racemization and chiral purity: the peptide impurity that is invisible to both HPLC and mass spectrometry
A D-amino acid impurity has the same mass as the target and often the same retention time. What racemization does to a peptide, and how it is measured.
-
Elemental impurities in synthetic peptides: what ICH Q3D covers and why HPLC cannot see it
Chromatographic purity says nothing about trace metals. Where elemental impurities enter synthetic peptides, and how ICP-MS characterizes them.
-
Peptide aggregation: why soluble oligomers are invisible to a purity certificate
Aggregation removes peptide from solution without altering mass or covalent structure — which is exactly why RP-HPLC and mass spectrometry do not detect it.
-
Asparagine deamidation: the one-dalton degradation route that purity assays miss
Asparagine deamidation is the slowest-looking and most consequential peptide degradation route: a one-dalton mass shift that standard purity assays miss.
-
Light exposure and peptide photodegradation: which residues absorb, and what happens next
Only a few amino acid residues absorb near-UV light, but their photochemistry drives most light-related peptide degradation. A look at the mechanisms.
-
Surface adsorption and peptide loss: container materials, low-concentration handling, and mass balance
Peptides adsorb to glass, plastic, and filter surfaces. At low concentrations this loss is large enough to distort analytical results. A look at the chemistry.
-
Where synthetic peptide impurities come from: deletion, truncation, and side-chain artifacts in SPPS
Most impurities in a synthetic peptide are created during synthesis, not during storage. A look at deletion sequences, truncations, and side-chain artifacts.
-
Peptide solubility: isoelectric point, net charge, and why some sequences resist reconstitution
Solubility is a sequence property, not a quality defect. How isoelectric point, net charge, and hydrophobic patterning govern whether a peptide dissolves.
-
Peptide counterions: what TFA and acetate salt forms mean for research material
Synthetic peptides are isolated as salts. Why trifluoroacetate dominates RP-HPLC purification, how acetate exchange works, and what counterion data mean.
-
Why two labs report different purity for the same peptide lot: RP-HPLC method variables
Two labs can report different purity figures for the same peptide lot. The RP-HPLC variables behind that gap: column chemistry, gradient slope, wavelength.
-
Endotoxin testing for research peptides: what LAL assays measure and what an EU/mg value means
Endotoxin is invisible to HPLC and mass spectrometry, so a 99% pure peptide can still carry a significant endotoxin burden. This post covers what the LAL assay detects and how to read an EU/mg figure on a certificate of analysis.
-
Peptide content vs chromatographic purity: why a 99% COA does not tell you how much peptide is in the vial
Chromatographic purity and peptide content measure different things. A lyophilate can be 99% pure by HPLC and still be 20% counterion and water by mass. This post covers the distinction and how each value is determined.
-
How mass spectrometry verifies peptide identity: MALDI-TOF vs ESI-MS
Purity and identity are separate questions, and chromatography only answers the first. This post covers how MALDI-TOF and ESI-MS establish that a peptide is the molecule it claims to be, and how to read the mass data on a certificate of analysis.
-
Freeze-thaw cycles and peptide integrity: what happens at the molecular level
Each freeze-thaw cycle exposes a peptide to cryoconcentration, ice-interface adsorption, and pH shifts. This post covers the degradation mechanisms and how aliquoting practice is designed around them.
-
GLP-1/GIP/Glucagon: The tri-agonist and multi-agonist peptide landscape in 2026
The obesity and metabolic peptide research space has shifted decisively toward multi-receptor agonists. This overview covers every major dual, triple, and combination agonist currently in clinical development.
-
Bacteriostatic water vs sterile water: the chemistry of peptide reconstitution
Bacteriostatic water contains 0.9% benzyl alcohol as a preservative; sterile water does not. This post explains what that difference means for peptide reconstitution chemistry, working stock stability, and analytical considerations.
-
Semaglutide COA: What to look for in a certificate of analysis
A certificate of analysis for research-grade semaglutide should report mass verification, HPLC purity, water content, and endotoxin. Here's what each value means and how to spot a legitimate lab report.
-
Retatrutide vs Tirzepatide: How triple- and dual-agonists differ
Retatrutide is a triple agonist at GLP-1, GIP, and glucagon receptors. Tirzepatide is a dual GLP-1/GIP agonist. This post explains what the third receptor changes about mechanism and metabolic effect.
-
What is Cagrilintide? An amylin analog research overview
Cagrilintide is a long-acting amylin analog studied for its effects on appetite regulation and glucose metabolism, most notably in combination with semaglutide (CagriSema). This overview covers its mechanism, pharmacology, and current research landscape.
-
Storage Solvent Chemistry: Diluents for Research Peptides
The diluent — the solvent used to reconstitute a lyophilized research peptide — is not a neutral choice. It determines the rate at which the dissolved peptide degrades, the stability of the working stock, the…
-
What is Mazdutide? An Oxyntomodulin-Derived Dual Agonist
Mazdutide (development codes IBI362 and LY3305677) is a synthetic dual-receptor research peptide engineered from the oxyntomodulin backbone — the natural human peptide that endogenously engages both the GLP-1 receptor…
-
GHRP-2 vs GHRP-6: A Growth Hormone Secretagogue Research Comparison
GHRP-2 and GHRP-6 are two of the founding members of the synthetic growth hormone-releasing peptide (GHRP) class — short peptide ghrelin-receptor agonists characterized in the late 1980s and early 1990s. Both bind the…
-
Liraglutide Research Overview: The Original Long-Acting GLP-1 Agonist
Liraglutide was the first long-acting glucagon-like peptide-1 (GLP-1) receptor agonist to be characterized at the molecular level, and remains the prototype research compound for studying acylation-mediated half-life…
-
The GLP-1 Research Landscape, Q2 2026
The incretin-axis research peptide category has expanded rapidly over the last five years. What was once a small set of GLP-1 receptor agonist research probes has grown into a multi-mechanism toolkit spanning…
-
Lyophilization Chemistry: Why Research Peptides Come as Powder
Open any research peptide vial from any vendor and the contents look the same: a thin layer of white-to-off-white powder or a small puck of friable solid at the bottom of the vial. That puck is the result of…
-
SS-31 (Szeto-Schiller Peptide) Mechanism: Mitochondria-Targeted Tetrapeptide
SS-31 — also designated elamipretide in the development literature, and named for its developers Hazel Szeto and Peter Schiller — is a small synthetic tetrapeptide engineered to selectively concentrate at the inner…
-
Tesamorelin Research Overview: GHRH Analog Mechanism and Preclinical Findings
Tesamorelin is a synthetic stabilized analog of growth hormone-releasing hormone (GHRH) — specifically, the GHRH(1-44) full-length sequence modified by attachment of a trans-3-hexenoyl moiety to the N-terminal tyrosine.…
-
What is Survodutide? A GLP-1/Glucagon Dual Agonist Research Overview
Survodutide (development code BI 456906) is a synthetic dual-receptor research peptide engineered to simultaneously activate the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR). In the…
-
MOTS-c: A Mitochondrial-Derived Peptide Research Overview
MOTS-c — “Mitochondrial Open Reading frame of the Twelve S rRNA type-c” — is a 16-amino-acid peptide encoded within the mitochondrial 12S ribosomal RNA gene. It is one of the most-studied members of the…
-
Sermorelin vs CJC-1295: A Research Comparison of GHRH Analogs
Sermorelin and CJC-1295 are both synthetic analogs of growth hormone-releasing hormone (GHRH), and both bind the same hypothalamic-pituitary GHRH receptor (GHRHR) to drive somatotroph signaling. The difference between…
-
Cagrilintide Mechanism and Amylin Biology: A Research Overview
Cagrilintide is a long-acting synthetic analog of human amylin — the pancreatic hormone co-secreted with insulin from β-cell granules in response to a glucose load. Where the incretin class (GLP-1, GIP) signals from the…
-
Reading a Tirzepatide CoA: What Each Value Means
A Certificate of Analysis is the only document that connects a vial of lyophilized white powder to a defined molecular identity. For a 39-amino-acid lipidated peptide like tirzepatide, the CoA carries unusual weight:…
-
Tirzepatide Mechanism Deep-Dive: GLP-1/GIP Dual Agonism in Research Context
Tirzepatide is the prototype dual-incretin research peptide — a synthetic 39-amino-acid analog engineered to simultaneously activate the glucagon-like peptide-1 receptor (GLP-1R) and the glucose-dependent insulinotropic…
-
FDA Peptide Enforcement: What 2026 Brought
The U.S. research peptide market underwent its biggest regulatory transition in a decade between late 2024 and early 2026.
-
Thymosin Alpha-1: Immune Modulation Research
Thymosin Alpha-1 is one of the most-studied immune-modulating peptides in the published literature.
-
GHK vs GHK-Cu: What’s the Difference in the Research?
Few questions come up more often in the peptide research category than this one: are GHK and GHK-Cu the same thing, and if not, which one does the published literature actually describe? The two names are used interchangeably in marketing copy, in supplier listings, and even in some review articles.
-
Understanding Peptide Purity: What 99% Actually Means
Almost every research peptide certificate of analysis (CoA) you'll pick up displays a purity figure — and that figure is almost always 99% or higher. On its face, this looks like a settled question: a vial is either pure or it isn't.
-
How to Verify a Peptide Lot in 90 Seconds
You have a vial in your hand. The label says BPC-157, 10 mg, with a lot number printed under the barcode.
-
BPC-157 vs. TB-500: A Research Comparison
BPC-157 and TB-500 are the two peptides most frequently compared in the tissue-repair and soft-tissue research literature.
-
Peptide Research Glossary: A Beginner’s Reference to the Terminology
The vocabulary of peptide research is its own dialect. A vial label, a Certificate of Analysis, and a published animal-research paper all assume the reader knows the basics: what a peptide actually is, what HPLC measures, what \"lyophilized\" means, what \"RUO\" stands for.
-
Why Third-Party CoAs Matter: An Industry-Standards Explainer for Research Peptide Buyers
A Certificate of Analysis (CoA) is the analytical record that a research-peptide vendor presents to attest to the identity and purity of a specific manufacturing lot.
-
Melanotan 2 and the Melanocortin Receptor Family: A Research Overview
Melanotan 2 (MT-II) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH), the endogenous melanocortin-system peptide derived from proopiomelanocortin (POMC).
-
Sermorelin and the GHRH Analog Class: A Research Overview
Sermorelin is a synthetic 29-amino-acid peptide that corresponds to the first 29 residues of growth hormone-releasing hormone (GHRH), the endogenous hypothalamic peptide that stimulates somatotroph release of growth hormone (GH) from the anterior pituitary.
-
Reconstitution Math: Calculating Concentration from a mg-per-Vial Lyophilized Peptide
A lyophilized research peptide arrives as a powder labeled with a gross mass — typically 5 mg, 10 mg, or higher. To use the compound in any research application, the powder must be dissolved in solvent, and the resulting solution must have a known, calculable concentration.
-
TB-500 (Thymosin Beta-4): A Research Overview of an Actin-Sequestering Peptide
TB-500 is a synthetic research peptide based on the 17-amino-acid active sequence of thymosin beta-4, a small actin-sequestering protein originally isolated from calf thymus in the early 1980s. The full-length parent molecule, thymosin beta-4, is the most abundant member of the b
-
Retatrutide vs. Semaglutide: A Research Comparison
Semaglutide and retatrutide are the two compounds most commonly compared in the current GLP-1 research literature, but the comparison is somewhat lopsided: semaglutide is an approved, marketed...
-
NAD+ in Research: Mechanism, Sirtuin Biology, and Storage Considerations
Nicotinamide adenine dinucleotide — NAD+ in its oxidized form — sits at the center of cellular metabolism and a body of aging-biology research that has expanded dramatically over the past decade....
-
GHK-Cu: The Copper Peptide in Skin and Tissue Research
GHK-Cu — the copper-bound complex of the tripeptide glycyl-L-histidyl-L-lysine — is one of the most-studied small peptides in regenerative biology. Loren Pickart's 1973 isolation of the GHK...
-
Lyophilized vs. Reconstituted Peptides: A Storage Protocol Guide
The lyophilized form of a research peptide is dramatically more stable than the reconstituted form — by orders of magnitude, in most cases. A properly stored lyophilized peptide maintains high...
-
BPC-157: A Complete Research Overview
BPC-157 — short for body protection compound 157, a pentadecapeptide first isolated from a fragment of human gastric juice protein — is one of the most-studied research peptides of the last twenty...
-
How to Read a Peptide Certificate of Analysis (CoA): A Practical Guide for Researchers
A peptide Certificate of Analysis is the single document that distinguishes a reproducible research input from a black box. The CoA is the vendor's claim about what is actually in the vial,...
-
How to Properly Store Research Peptides: A Complete Guide
Best practices for storing lyophilized and reconstituted research peptides, including temperature guidelines, reconstitution tips, and common mistakes to avoid.
-
Understanding Certificates of Analysis (COAs): Why They Matter
Learn how to read and evaluate a Certificate of Analysis (COA), why third-party testing matters, and what to look for when sourcing research peptides.
-
What Are Peptides? A Comprehensive Guide for Researchers
A detailed overview of peptides — what they are, how they differ from proteins, and why they are essential tools in modern scientific research.